Pharma Surge
Pharma Surge
Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

9,577 stories indexed, page 144 of 160

🌍Researchcaprisa.org

Get to know our Scientists

CAPRISA ResearchOriginal source
🌍Researchcaprisa.org

NIHR-funded studies

CAPRISA ResearchOriginal source
🌍Researchcaprisa.org

HIV Prevention and Epidemiology

CAPRISA ResearchOriginal source
🌍Researchcaprisa.org

EDCTP-funded studies

CAPRISA ResearchOriginal source
🌍Researchcaprisa.org

CAPRISA Centres of Excellence

CAPRISA ResearchOriginal source
🇨🇦Regulatorycanada.ca

Transport and infrastructure

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Policing, justice and emergencies

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Manage life events

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Immigration and citizenship

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Environment and natural resources

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

National security and defence

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Culture, history and sport

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Phenytoin sodium capsules and phenytoin chewable tablets in short supply: Notice

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Glucagon for injection supply in Canada: Notice

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Post-notice of compliance changes

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

International Council for Harmonisation (ICH)

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Policy statement: Reconsideration of decisions for priority review status and advance consideration of Notice of Compliance with conditions (NOC/c)

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Final notice: Classification of topical products containing human-derived exosomes, human extracellular vesicles, or human cell-conditioned media

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Drug products

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Updated: Guidance on nitrosamine impurities in medications

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

New website for health product shortages

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Drugs and health products

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Closed consultation on the proposed phased implementation of the incorporated by reference list for the Ministerial Reliance Order

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

What we heard: Draft guidance on decentralized clinical trials

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Consultation: Canadian Access, Watch, Reserve classification of antimicrobial drugs for human use

Health CanadaOriginal source
🇺🇸CDMOcaidya.com

November 2025 Caidya Reimagines Next Generation Clinical Trial Innovation and Study Delivery with Medidata AI-Powered Experiences

CaidyaOriginal source
🇺🇸CDMOcaidya.com

February 2026 Caidya Names Michael Clay COO to Drive Operational Excellence and Advance Multi-Regional Clinical Development

CaidyaOriginal source
🇺🇸CDMOcaidya.com

July 2025 Caidya’s John Wang Named Chair of China CDISC Coordinating Committee; Medidata Accreditation Underscores Data Management Excellence

CaidyaOriginal source
🇺🇸CDMOcaidya.com

CROs dMed and Clinipace merge to accelerate customer success - Caidya®

CaidyaOriginal source
🇺🇸CDMOcaidya.com

Caidya Wins CRO Leadership Award for Overall Capabilities - Caidya®

CaidyaOriginal source
🇺🇸CDMOcaidya.com

Clinipace Name Change: Introducing Caidya, a New Name for a Leading Global CRO - Caidya®

CaidyaOriginal source
🇺🇸CDMOcaidya.com

Caidya’s Miles Pan Named to Legal 500 GC Powerlist China 2025 - Caidya®

CaidyaOriginal source
🇺🇸CDMOcaidya.com

Caidya Welcomes Jay Roberts to its Board of Directors - Caidya®

CaidyaOriginal source
🇺🇸CDMOcaidya.com

Caidya Strengthens European Growth Strategy and Appoints Mario Bautista as Head of Business Development, Europe - Caidya®

CaidyaOriginal source
🇺🇸CDMOcaidya.com

Caidya Names Brandon Pallott as CCO to Drive Innovative Commercial Initiatives and Market Expansion - Caidya®

CaidyaOriginal source
🇺🇸CDMOcaidya.com

Caidya Expands Global Presence with the Establishment of Caidya Canada Limited and New Office in Toronto - Caidya®

CaidyaOriginal source
🇺🇸CDMOcaidya.com

Caidya Appoints Dr. Bin Peng as Chair of its China Scientific Advisory Board - Caidya®

CaidyaOriginal source
🇺🇸CDMOcaidya.com

Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders - Caidya®

CaidyaOriginal source
🇺🇸CDMOcaidya.com

Caidya Announces Appointment of Barbara Lopez Kunz to Board of Directors - Caidya®

CaidyaOriginal source
🇺🇸CDMOcaidya.com

Caidya Achieves Medidata Rave TSDV Accreditation, Enhancing Clinical Trial Efficiency and Data Integrity - Caidya®

CaidyaOriginal source
🇺🇸CDMOcaidya.com

Caidya Strengthens Therapeutic Leadership: Names Adam Callahan Head of Oncology and Hematology - Caidya®

CaidyaOriginal source
🇺🇸CDMOcaidya.com

Caidya Announces Leadership Transition: Barbara Lopez Kunz Named CEO - Caidya®

CaidyaOriginal source
🇺🇸Industrycabalettabio.com

Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress

Cabaletta BioOriginal source
🇺🇸Industrycabalettabio.com

Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update

Cabaletta BioOriginal source
🇺🇸Industrycabalettabio.com

Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting

Cabaletta BioOriginal source
🇺🇸Industrycabalettabio.com

Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering

Cabaletta BioOriginal source
🇺🇸Industrycabalettabio.com

Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel

Cabaletta BioOriginal source
🇺🇸Industrycabalettabio.com

Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting

Cabaletta BioOriginal source
🇺🇸Industrycabalettabio.com

Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Cabaletta BioOriginal source
🇺🇸Industrycabalettabio.com

Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference

Cabaletta BioOriginal source
🇺🇸Industrycabalettabio.com

Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Cabaletta BioOriginal source
🇺🇸Industrycabalettabio.com

Cabaletta Bio Announces 2026 Strategic Priorities

Cabaletta BioOriginal source
🇺🇸Researchbroadinstitute.org

News 08.15.2025

Broad InstituteOriginal source
🇺🇸Researchbroadinstitute.org

News 09.24.2025

Broad InstituteOriginal source
🇺🇸Researchbroadinstitute.org

News 07.31.2025

Broad InstituteOriginal source
🇺🇸Researchbroadinstitute.org

News 11.19.2025

Broad InstituteOriginal source
🇺🇸Researchbroadinstitute.org

News 06.24.2025

Broad InstituteOriginal source
🇺🇸Researchbroadinstitute.org

News 07.21.2025

Broad InstituteOriginal source
🇺🇸Researchbroadinstitute.org

News 12.17.2025

Broad InstituteOriginal source